Exor focuses on renewables and invests in TagEnergy
MILAN - Exor focuses on renewable energy. It will join forces with Impala, an investment company controlled by Jacques Veyrat...
MILAN - Exor focuses on renewable energy. It will join forces with Impala, an investment company controlled by Jacques Veyrat...
Lingotto, an investment company of the Exor holding (which controls the publisher of RepublicGedi), has become an investor in the...
Listen to the audio version of the articleLube, the kitchen manufacturer group from the Marche region, accelerates its expansion abroad,...
Listen to the audio version of the articleAdditive printing, alongside applications related to artificial intelligence, available to SMEs to accelerate...
Listen to the audio version of the articleA total investment expected at the end of the process, for the next...
NEOS ON THE DEVELOPMENT ROUTEThe growth path of the company continues, supported by investments aimed at training and specialization and...
Listen to the audio version of the articleIn a period in which Italian manufacturing seems to be taking a breather...
the largest foreign investment in the history of our country. Within a week this sentence was pronounced by the heads...
Listen to the audio version of the articleThe Credit Agricole group invests in the Illy family's Polo del gusto. Through...
Intesa Sanpaolo accelerates on digital with the aim of becoming the first online operator in the credit sector. And it...
Two hundred million dollars over the next ten years: an investment that aims in a very concrete way to accelerate...
Listen to the audio version of the articleFor the workers of the Intesa Sanpaolo group comes the increase on the...
Stellantis invests with Michelin and Faurecia in Symbio, leader of hydrogen mobility. The automotive group, born from the merger of...
Listen to the audio version of the articleBonduelle will invest 10 million euros in Italy over the next three years....
Listen to the audio version of the articleAngelini pharma invests in the treatment of epilepsy. The company has in fact...